Latest News Releases From The Newsroom
Market Buzz: Astronics Previews Q2 Revenue, FB Financial Posts Earnings Beat
July 17th, 2023
Astronics Corporation (Nasdaq: ATRO) revealed that preliminary orders for the second quarter of 2023 are estimated to be in the range of $200M to $205M. Additionally, unaudited preliminary results indicate that the company's revenue for the . Read more
Goldman Sachs' Buy Views: Yelp, Stagwell, and Chewy
July 17th, 2023
Yelp Inc. (NYSE: YELP), a popular online platform for local businesses, received a notable upgrade from Goldman Sachs, shifting its rating from Neutral to Buy, and the investment firm announced a price target of $47. With $YELP closing at $38.13 o. Read more
Making Waves: GreenPower Q4 Revenue Beats; Analysts See Upside On Wells Fargo
July 17th, 2023
GreenPower Motor Company Inc. (Nasdaq: GP), a leading electric vehicle manufacturer, reported strong fourth-quarter fiscal 2023 revenues of $15.3 million, marking an impressive 255% year-over-year increase. The results exceeded consensus estimates of. Read more
Q2 Earnings Preview: Goldman Sachs, Elevance Health, U.S. Bancorp
July 16th, 2023
On Wednesday, July 19, several companies are set to reveal their financial performance, including: The Goldman Sachs Group, Inc. (NYSE: GS), a renowned global investment banking firm, will announce its second quarter 2023 financial results before . Read more
Key Upcoming Date: Pinnacle Financial, Western Alliance, and Hancock Whitney
July 16th, 2023
Several companies are scheduled to report their financial results on Tuesday, July 18, including: Pinnacle Financial Partners, Inc. (Nasdaq: PNFP), a financial services company, is set to release its second-quarter 2023 financial results after the. Read more
Acumen Pharma's ACU193 Shows Potential in Alzheimer's Trial; Bullish View for EnerSys
July 16th, 2023
Acumen Pharmaceuticals, Inc. (Nasdaq: ABOS) announced positive topline results from the Phase 1 INTERCEPT-AD trial evaluating the company's ACU193, a clinical-stage antibody therapy targeting amyloid beta oligomers (AβOs) in early Alzheimer's di. Read more
Earnings Figures Expected: PNC Financial, BNY Mellon, and Omnicom
July 16th, 2023
On Tuesday, July 18, several companies are anticipated to report their financial results, including: The PNC Financial Services Group, Inc. (NYSE: PNC), a financial services corporation, is set to issue its financial results for the second quarter. Read more
Bank of America, Novartis, and Morgan Stanley: Earnings Preview
July 16th, 2023
On Tuesday, July 18, several companies are expected to report their financial results, including: Bank of America Corporation (NYSE: BAC), a financial giant, is set to reveal its second-quarter 2023 financial results before the market opens. . Read more
Breaking: FTC Seeks More Info on Pfizer's Seagen Merger Plan
July 15th, 2023
Seagen Inc. (Nasdaq: SGEN) and Pfizer Inc. (NYSE: PFE) have encountered a regulatory hurdle in their planned merger. According to a regulatory filing with the SEC, both companies received a Second Request from the Federal Trade Commission (FTC) on Ju. Read more
US Designates Former Panamanian President Juan Carlos Varela Rodriguez for Significant Corruption
July 14th, 2023
In a decisive move, U.S. Secretary of State Antony J. Blinken has announced the designation of former Panamanian President Juan Carlos Varela Rodriguez as generally ineligible for entry into the United States due to his involvement in significant cor. Read more
Want To Find Some News?
News By Industries
Recent Posts
-
Micron Technology, Jabil, and Birkenstock Earnings Preview: What to Expect
December 15th, 2024Upcoming Earnings: Synopsys, AeroVironment, and nCino in Focus
December 01st, 2024Countdown to Earnings: Salesforce, Marvell Technology, and Okta Take the Stage
December 01st, 2024Fluence Energy, Agilent Technologies, and Woodward Earnings On Deck: A Preview
November 24th, 2024Earnings Preview: Walt Disney, Applied Materials, and Celcuity Take Center Stage
November 11th, 2024
Member Login